ECHA management board elects new deputy chairman

Martin Lynch takes the role

The European Chemicals Agency (ECHA) in Helsinki, Finland has elected Martin Lynch as deputy chairman of its management board.

Lynch, from Ireland, will hold the role for the next two years. Dr Thomas Jakl, from Austria, is chairman.

You may also like

Ingredients

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride
Manufacturing

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers
Ingredients

dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan

The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
Ingredients

Sigrid Therapeutics' Glucose Stabiliser listed on US e-commerce site, GetHealthy.store

The non-pharmaceutical silica solution can assist patients in managing their blood sugar, while reducing bloating and increasing energy levels
Ingredients

ICROM has acquired HOLODIAG

ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of small molecules
Ingredients

Olon continues its growth with a new acquisition

The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence
Ingredients

Familial chylomicronaemia syndrome: olezarsen

Familial chylomicronaemia syndrome (FCS) is a rare genetic disease that causes extremely high levels of triglycerides. It is the result of the enzyme lipoprotein lipase not working properly, which leaves patients unable to break down chylomicrons effectively
Subscribe now